PART I — FINANCIAL INFORMATION Item 1. Financial Statements The company reported a wider net loss on lower revenue, but a public offering significantly improved its financial position Condensed Consolidated Balance Sheets The balance sheet shows improved liquidity and a shift from a stockholder deficit to equity due to a recent capital raise Key Financial Metrics | Financial Metric | March 31, 2023 (in thousands) | December 31, 2022 (in thousands) | Change | | :--- | :--- | :--- | :--- | | Cash | $3,948 | $110 | +$3,838 | | Total Current Assets | $6,019 | $1,863 | +$4,156 | | Total Assets | $11,276 | $6,965 | +$4,311 | | Total Current Liabilities | $2,648 | $4,829 | -$2,181 | | Total Liabilities | $6,981 | $9,145 | -$2,164 | | Total Stockholders' Equity (Deficit) | $4,295 | $(2,180) | +$6,475 | Condensed Consolidated Statements of Operations Revenue declined while operating expenses increased, resulting in a larger net loss compared to the prior-year period Quarterly Operational Performance | Metric (in thousands, except per-share data) | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | | :--- | :--- | :--- | | Revenue | $2,455 | $2,737 | | Gross Profit | $(24) | $(95) | | Selling, general and administrative expenses | $2,691 | $2,008 | | Loss from operations | $(2,715) | $(2,103) | | NET LOSS | $(2,879) | $(2,606) | | Net Loss per common share - basic and diluted | $(2.21) | $(15.40) | - The net loss per share improved significantly from $(15.40) to $(2.21) year-over-year, primarily due to a substantial increase in the weighted-average number of common shares outstanding following recent stock issuances13 Condensed Consolidated Statements of Stockholders' Equity (Deficit) A public offering drove a significant increase in stockholders' equity, offsetting the quarterly net loss - A public offering in Q1 2023 resulted in the issuance of 1,619,000 shares of common stock, generating $9.26 million in additional paid-in capital, net of expenses15 - The number of outstanding common shares increased from 362,716 at December 31, 2022, to 1,989,645 at March 31, 202315 Condensed Consolidated Statements of Cash Flows Financing activities from a public offering funded cash outflows from operations and investments, boosting cash reserves Quarterly Cash Flow Summary | Cash Flow Activity (in thousands) | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | | :--- | :--- | :--- | | Net Cash Used in Operating Activities | $(3,319) | $(1,279) | | Net Cash Used in Investing Activities | $(361) | $(19) | | Net Cash Provided by Financing Activities | $7,518 | $1,285 | | Net Change in Cash | $3,838 | $(13) | | Cash at End of Period | $3,948 | $18 | Notes to Unaudited Condensed Consolidated Financial Statements Notes highlight substantial going concern doubt, significant customer concentration, and details of a recent public offering - Management has substantial doubt about the company's ability to continue as a going concern due to recurring net losses and its dependency on raising additional capital309498 - The company faces significant customer concentration risk, with three customers accounting for approximately 69% of total revenue in Q1 2023 and 80% of gross outstanding trade receivables35 - In February 2023, the company completed a public offering, raising approximately $10.2 million in gross proceeds by issuing 1,619,000 shares of common stock and warrants71 - The company settled two legal matters during the quarter: one with Green City Growers for $120,000 and another with a former officer for $235,0008990 Revenue by Segment | Revenue Stream (in thousands) | Q1 2023 | Q1 2022 | | :--- | :--- | :--- | | Herbs & Produce | $1,832 | $2,410 | | Vitamins and Supplements | $623 | $327 | | Total | $2,455 | $2,737 | Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Management discusses a revenue decline in core business, rising SG&A costs, and improved liquidity from a recent offering - Revenue decreased 10.3% YoY, driven by a $578 thousand (24%) decrease in the herbs and produce business, while the vitamins and supplements segment grew by $296 thousand (90.5%)123 - SG&A expenses increased by $684 thousand (34%) YoY, primarily due to costs related to the new Grand Rapids facility ($217k) and increased public company costs ($418k)127 - Gross margin improved from -3.47% in Q1 2022 to -0.98% in Q1 2023, which management attributes to the impact of price increases126 - The company raised approximately $10.2 million in gross proceeds from a public offering in February 2023, which management believes is sufficient to fund operations through December 2023136137 - Management reiterates that there is substantial doubt about the company's ability to continue as a going concern due to its history of significant losses and reliance on external financing132133 Item 3. Quantitative and Qualitative Disclosures About Market Risk The company is exempt from market risk disclosure requirements as a smaller reporting company - As a smaller reporting company, Edible Garden is not required to provide quantitative and qualitative disclosures about market risk143 Item 4. Controls and Procedures Management concluded that disclosure controls were ineffective due to material weaknesses in internal financial reporting - Management concluded that as of March 31, 2023, the company's disclosure controls and procedures were ineffective144 - The ineffectiveness is due to material weaknesses in internal control, including a lack of adequate segregation of duties because of the small size of the finance department145 PART II — OTHER INFORMATION Item 1. Legal Proceedings The company settled and dismissed two separate legal claims during the first quarter of 2023 - The company settled a lawsuit with Green City Growers Cooperative concerning an alleged breach of a supplier agreement for an aggregate payment of $120,000148149 - A breach of contract claim filed by a former officer was settled for an aggregate payment of $235,000 and dismissed in February 2023150 Item 6. Exhibits This section lists all exhibits filed with the report, including agreements, warrants, and officer certifications - The report lists exhibits filed, including the Underwriting Agreement from the February 2, 2023 public offering, forms of warrants, and required officer certifications151
Edible Garden AG rporated(EDBL) - 2023 Q1 - Quarterly Report